DistressOther
Clarus Therapeutics Holdings, Inc. acquired JATENZO®
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Clarus Therapeutics Holdings, Inc. -> JATENZO®
"After thoroughly exploring our strategic options in a robust process conducted by the Capital Structure Advisory team at Raymond James, and in light of the extremely challenging financial markets, Clarus' Board of Directors and its senior management team have
Open source record (SEC) ↗